Michael Lee
Allergy & Immunology · Richmond, CANPI 1609370014
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 75 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by GSK at 25.7% of the total. Reporting peaked in 2023 at $1,467 and has fallen 96.3% since, to $54 in 2025.
Across 75 payments — averaging $54.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1K
- AstraZeneca$614
- Regeneron Healthcare Solutions, Inc.$360
- Sanofi$299
- Takeda Pharmaceuticals U.S.A., Inc.$295
- Grifols USA, LLC$268
- plus $1K from 15 others
What the payments were for
- Food & beverage$4,075100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 23 | $1,048 |
| AstraZeneca | 9 | $614 |
| Regeneron Healthcare Solutions, Inc. | 6 | $360 |
| Sanofi | 3 | $299 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $295 |
| Grifols USA, LLC | 3 | $268 |
| Pharming Healthcare, Inc. | 3 | $172 |
| Genentech, Inc. | 1 | $150 |
| Biocryst US Sales Co., LLC | 2 | $141 |
| Amgen(2 entities) | 3 | $128 |
| Merz North America, Inc. | 4 | $102 |
| AbbVie | 1 | $101 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Teva Pharmaceuticals USA, Inc. | 1 | $77 |
| Alk-abello, Inc | 1 | $50 |
| CSL Behring | 2 | $44 |
| Merck | 2 | $39 |
| Boehringer Ingelheim | 2 | $34 |
| Incyte Corporation | 1 | $20 |
| Kaleo, Inc. | 1 | $19 |
| Revance Therapeutics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,075 in reported general payments places this provider in the 60th percentile of 426 allergy & immunology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BreynaBudesonide/Formoterol Fumarate | 16 | $9,156 |
| Azelastine Hcl | 55 | $929 |
| Ipratropium Bromide | 33 | $796 |
| Fluticasone Propionate | 15 | $425 |
| Prednisone | 13 | $98 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in Richmond
- Raffi TachdjianSanta Monica$3.7M
- Bob GengSan Diego$3.3M
- Vinay MehtaLaguna Niguel$1.3M
- Andrew WhiteSan Diego$752K
- Marc RiedlSan Diego$725K
- Katharine WoessnerSan Diego$581K
- Brian Modenala Jolla$453K
- Heena Shah PatelUpland$428K
- Jacob OffenbergerGranada Hills$419K
- Myron LiebhaberSanta Barbara$354K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.